Search for: "TEVA USA, INC." Results 341 - 360 of 646
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Pharma & Biotech Global Week in Review 18 Nov 09 from IP Think Tank
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 18 Nov 09 from IP Think Tank
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 18 Nov 09 from IP Think Tank
18 Nov 2009, 4:57 am
Teva Pharmaceuticals USA Inc. et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
District Court Rules that Broad Measure of Damages Applies in False Claims Act Case, Greatly Increasing Defendants’ Exposure
21 Jul 2023, 4:47 pm by luiza
Teva Pharmaceuticals USA, Inc., No. 1:20-cv-11548 (D. [read post]
Whistleblower Insider - https://constantinecannon.com/practice/whistleblower/blog/
Safe Harbor Provision for Divisional Patent Applications
8 Oct 2009, 12:37 pm by James Yang
Teva Pharmaceuticals USA, Inc. 518 F.3d 1353 (Fed. [read post]
OC Patent Lawyer - http://ocpatentlawyer.com
Google et al. lose claim construction issue in HBAC case at CAFC
1 Jun 2016, 4:49 pm by Lawrence B. Ebert
USA, Inc., 395 F.3d 1364, 1372(Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Certiorari Denied in Eligibility Cases
15 May 2023, 7:21 am by Dennis Crouch
” This petition has a minimal likelihood of being granted. = = = = The court also denied certiorari in the skinny-label FDA-Patent case of Teva Pharmaceuticals USA, Inc. v. [read post]
Patently-O - https://patentlyo.com
CAFC limits Warsaw Orthopedic to "reasonable royalty"
3 Mar 2015, 4:55 pm by Lawrence B. Ebert
USA, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Pharma & Biotech Global Week in Review 28 July 2010 from IP Think Tank
28 Jul 2010, 12:06 am by Kelly
Teva Pharmaceuticals USA, Inc. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 13 October 2010 from IP Think Tank
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Differentiating patent attorneys
11 Dec 2008, 10:30 pm
(DRL); and Teva Pharmaceuticals USA, Inc. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC vacates D. Mass. in Lexington Luminance case; holding of indefiniteness reversed
9 Feb 2015, 2:52 pm by Lawrence B. Ebert
USA, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Will High Court Curb the Federal Circuit?
31 Mar 2014, 2:16 pm by Barry Barnett
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
Blawgletter - http://blawgletter.typepad.com/bbarnett/
Split decision in Virnetx v/ Apple
22 Nov 2019, 2:56 pm by Lawrence B. Ebert
USA, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Novartis prevails at CAFC
14 May 2019, 11:24 am by Lawrence B. Ebert
USA, Inc., 566 F.3d 989, 994(Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
CAFC reverses ITC by 2-1 vote in One-E-Way case; lengthy dissent by CJ Prost
12 Jun 2017, 5:40 pm by Lawrence B. Ebert
USA, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Pharma & Biotech Global Week in Review 8 September 2010 from IP Think Tank
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
GOT HYPERTENSION?
9 Apr 2010, 8:30 am by Lucas A. Ferrara, Esq.
Both products are manufactured by TEVA Pharmaceuticals USA in North Wales, Pa. [read post]
Real Estate Law Blog - http://www.nyrealestatelawblog.com/
Obviousness Type Double Patenting Does Not Require Later-Issued Patent With Shorter Term to Abridge Term of Earlier-Granted Patent With Longer Term
12 Jan 2011, 6:55 am by The Docket Navigator
Teva Pharmaceuticals USA Inc., et. al., 1-08-cv-00464 (DED January 7, 2011, Order) (Bartle, C.J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Section 121 safe harbor applies only to divisional, not continuation-in-part; later patent invalid
12 Mar 2008, 8:50 pm
USA, Inc. after the jump. [read post]
Filewrapper.com - http://www.filewrapper.com/index.cfm